Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs Livea

By GLP-1 ScorecardUpdated

CoraDocFactor scores not reassessed.
Site position #49

Higher score

LiveaFactor scores not reassessed.
Site position #130

Lower score

Score comparison

CoraDoc has the higher recorded score — 76.8/100 to 69.7/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc advertises one upfront payment for a selected GLP-1 program. Its sales page and written refund policy give different answers about what you may get back.

Before you choose

Before comparing the headline prices, the CoraDoc review and the Livea review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CoraDoc vs NewSelf and CoreAge Rx vs Livea compare each of them with another graded program, and the list of alternatives to CoraDoc ranks the programs closest to CoraDoc on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoraDoc +42
96
54
Dose & formulationCoraDoc +8
72
64
Clinical oversightLivea +14
79
93
Labs & monitoringLivea +20
53
73
FulfillmentLivea +3
76
79
Contract termsCoraDoc +14
69
55
CoraDoc · top barLivea · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoraDocLivea
WeighScore76.8/10069.7/100
GradeCC
Site position#49#130
Semaglutide$924 upfront (12-month promotion, compounded)$99/mo (plus a separate fee, compounded)
Tirzepatide$1,524 upfront (12-month promotion, compounded)$199/mo (compounded)
CoverageCoverage not published4 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoraDoc

Site position #49 · C

Factor scores not reassessed.

Strengths

  • The 12-month promotion publishes the one-time payment for each medication
  • The campaign lists clinician visits, medication, dose increases, shipping and supplies as included
  • The weight-loss campaign advertises no automatic renewal for the annual offer

What to consider

  • The lowest advertised monthly equivalents require paying for 12 months at once
  • The refund policy describes a possible $100 clinical fee after medical ineligibility, despite the sales-page full-refund promise
  • The pages checked did not name the dispensing pharmacy for an individual order
Livea

Site position #130 · C

Factor scores not reassessed.

Strengths

  • LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
  • Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
  • Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
  • 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
  • Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible

What to consider

  • Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
  • Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
  • Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
  • Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
  • Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard